Stellbrink, Hans-Jürgen <br/><br/>
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Oct 2010 
 - 963-72 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1086/656417  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Adenine--administration & dosage<br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-HIV Agents--administration & dosage<br/>Bone Density--drug effects<br/>Bone and Bones--pathology<br/>Deoxycytidine--administration & dosage<br/>Dideoxynucleosides--administration & dosage<br/>Drug Combinations<br/>Emtricitabine<br/>Europe<br/>Female<br/>HIV Infections--drug therapy<br/>Humans<br/>Lamivudine--administration & dosage<br/>Male<br/>Middle Aged<br/>Organophosphonates--administration & dosage<br/>Tenofovir<br/>Young Adult